Postmortem studies of AD brains confirm reduced insulin receptor expression, impaired insulin transport across the BBB, and increased levels of insulin-degrading enzyme (IDE), which competes with Aβ for degradation [59]. This evidence concerns the gene IDE and Alzheimer disease.